ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
2 announcements with these filters
Concord Drugs Limited confirmed it does not qualify as a 'Large Corporate' as of March 31, 2026, under SEBI's debt issuance framework. Consequently, mandatory borrowing requirements through debt securities are not applicable for FY 2025-26.
Concord Drugs Ltd has submitted its initial disclosure under the SEBI Large Corporate framework for the financial year ending March 31, 2026. The company reported outstanding borrowings of ₹10.00 Crore. This filing confirms compliance with debt-raising norms mandated for entities identified as Large Corporates.